Lebrikizumab treatment in adults with asthma.
摘要：
tohe editor:orrenndolleagues evaluatedheelevancef interleukin-13 in patients withncontrolledsthma.heyelected patients whoadeenaking inhaled glucocorticoidsort least 6onthsnd whoad evidencefncontrolledsthma.ncontrolledsthma was definedscoreigherhan 1.5nheymptom-only versionfhesthmaontrol Questionnaire 5 (ACQ5).heuthors presumedhatncontrolledsthma was dueoteroidesistancenly.owever,herereanyeasons whysthmaay noteontrolled,uchs noncompliance, poor inhalerechnique, gastroesophagealeflux disease,moking,ndir pollution. Noncompliance with inhalededicationsaseenhownoehe leadingactoresponsibleorncontrolledsthma.
展开
关键词：
Interleukin-13 Asthma Difference In The Frequency Antiinflammatory Effects Adults Patients With Asthma Editor Lung Function High Pretreatment Levels Lebrikizumab FEV-1 Frequency Of Exacerbations Increase In FEV Still Debatable Patients With Evidence
DOI：
10.1056/NEJMc1112234#SA2
被引量：
年份：
2011
相似文献
参考文献
引证文献
引用走势
站内活动
辅助模式
引用
文献可以批量引用啦~
欢迎点我试用！
